10.40
-0.21 (-1.98%)
| Previous Close | 10.61 |
| Open | 10.47 |
| Volume | 798,463 |
| Avg. Volume (3M) | 1,065,615 |
| Market Cap | 1,408,413,056 |
| Price / Earnings (TTM) | 18.91 |
| Price / Earnings (Forward) | 8.76 |
| Price / Sales | 0.410 |
| Price / Book | 0.810 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 2.63% |
| Operating Margin (TTM) | 3.63% |
| Diluted EPS (TTM) | 0.580 |
| Quarterly Revenue Growth (YOY) | -1.80% |
| Quarterly Earnings Growth (YOY) | 39.00% |
| Total Debt/Equity (MRQ) | 133.64% |
| Current Ratio (MRQ) | 1.29 |
| Operating Cash Flow (TTM) | 588.33 M |
| Levered Free Cash Flow (TTM) | 154.64 M |
| Return on Assets (TTM) | 3.82% |
| Return on Equity (TTM) | 5.90% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | AdaptHealth Corp. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | 1.5 |
| Price Volatility | -4.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -1.30 |
|
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 8.16% |
| % Held by Institutions | 102.35% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Oep Capital Advisors, L.P. | 30 Sep 2025 | 13,818,180 |
| Skyknight Capital, L.P. | 30 Sep 2025 | 8,580,443 |
| 52 Weeks Range | ||
| Median | 12.00 (15.39%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Leerink Partners | 26 Feb 2026 | 12.00 (15.38%) | Buy | 9.33 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| REW RICHARD W. II | 9.33 | - | 5,000 | 46,650 |
| Aggregate Net Quantity | 5,000 | |||
| Aggregate Net Value ($) | 46,650 | |||
| Aggregate Avg. Buy ($) | 9.33 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| REW RICHARD W. II | Officer | 26 Feb 2026 | Buy (+) | 5,000 | 9.33 | 46,650 |
| Date | Type | Details |
|---|---|---|
| 03 Feb 2026 | Announcement | AdaptHealth Corp. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call |
| 27 Jan 2026 | Announcement | AdaptHealth Corp. Announces Upgraded Moody’s Ratings |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |